Drug Interaction Report

Insulin Detemir and Acarbose: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Acarbose

Prandase® Precose Precose®
+

Insulin Detemir

Levemir
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 75 documented Insulin Detemir interactions, 36 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Taking acarbose with insulin detemir adds up to a greater chance of low blood sugar, so your insulin dose may need adjusting and your sugars monitored more closely; if you go low, treat it with glucose tablets rather than table sugar.

Both of these medicines lower your blood sugar, just in different ways. Insulin detemir (Levemir) directly lowers blood sugar, and acarbose (Precose) slows how fast your body absorbs sugar from food. When you take them together, their effects add up, so your blood sugar could drop too low. This is called hypoglycemia.

Signs of low blood sugar include shakiness, sweating, dizziness, confusion, or feeling very hungry. The good news is your care team is used to managing this. They may adjust your insulin dose and check your sugars a bit more closely. Keep taking both as prescribed and talk with your pharmacist or doctor about how to watch for lows.

Effect: Additive glucose-lowering, increasing the risk of hypoglycemia. Neither agent is an inhibitor/inducer; this is a pharmacodynamic (PD), not pharmacokinetic, interaction.

  • Mechanism: Acarbose (alpha-glucosidase inhibitor) plus basal insulin detemir produces additive reduction in blood glucose.
  • Direction: Enhanced hypoglycemic effect.
  • Onset: Unspecified.
  • Evidence: Theoretical; severity rated major given hypoglycemia risk.
  • Management: Insulin dose may need reduction and individualization; reinforce glucose self-monitoring and hypoglycemia recognition. Note: treat acarbose-associated hypoglycemia with oral glucose (dextrose), not sucrose, since acarbose delays sucrose breakdown.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of hypoglycemia

Interaction Deep Dive

When oral antidiabetic drugs are taken together with insulin 1 or pramlintide 2, glucose metabolism can be affected, potentially raising the likelihood of hypoglycemia. A reduction in the insulin dose may be required when it is combined with oral antidiabetic agents 3.

Why it happens (mechanism)

Altered glucose metabolism; additive hypoglycemia

How to manage this interaction

This combination is commonly used and can be managed safely. Because both medicines lower blood sugar, your care team watches for lows.

  • Keep taking both exactly as prescribed unless your doctor tells you otherwise.
  • Your insulin dose may need to be adjusted and individualized by your care team.
  • Your team may ask you to monitor your blood sugar more closely, especially when starting.
  • Learn the signs of low blood sugar (shaky, sweaty, dizzy, confused) and keep a fast sugar source handy.
  • Important: if you have a low while on acarbose, use glucose (dextrose) tablets or gel, not table sugar, since acarbose slows the breakdown of table sugar.

Raise any lows with your pharmacist or prescriber.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Insulin Detemir and Acarbose together?

Taking acarbose with insulin detemir adds up to a greater chance of low blood sugar, so your insulin dose may need adjusting and your sugars monitored more closely; if you go low, treat it with glucose tablets rather than table sugar. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Insulin Detemir and Acarbose interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Insulin Detemir and Acarbose interaction managed?

This combination is commonly used and can be managed safely. Because both medicines lower blood sugar, your care team watches for lows. Keep taking both exactly as prescribed unless your doctor tells you otherwise. Your insulin dose may need to be adjusted and individualized by your care team. Your team may ask you to monitor your blood sugar more closely, especially when starting. Learn the signs… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Insulin Detemir or Acarbose need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: Tresiba subcutaneous injection solution, insulin degludec subcutaneous injection solution. Novo Nordisk A/S (per EMA), Bagsvaerd, Denmark, 2013. DailyMed
  2. Product Information: SYMLIN(R) subcutaneous injection, pramlintide acetate subcutaneous injection. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2016. DailyMed
  3. Product Information: GLYXAMBI(R) oral tablets, empagliflozin linagliptin oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per manufacturer), Ridgefield, CT, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.